GSK Aktie
17,29
EUR
+0,10
EUR
+0,58
%
14,94
GBP
-0,17
GBP
-1,13
%
Werbung
GSK Aktie Analyse
28.04.05 | GSK Kaufen | BHF-BANK | |
27.04.05 | GSK Sector Underperform | Vontobel | |
26.04.05 | GSK In-Line | Goldman Sachs | |
25.04.05 | GSK Halten | Helaba Trust | |
18.04.05 | GSK In-Line | Goldman Sachs | |
18.04.05 | GSK Overweight | Lehman Brothers | |
15.04.05 | GSK Neutral | HypoVereinsbank | |
07.03.05 | GSK In-Line | Goldman Sachs | |
Werbung
|
|||
07.03.05 | GSK Overweight | Lehman Brothers | |
04.03.05 | GSK Outperform | Credit Suisse First Boston | |
16.02.05 | GSK Kaufen | LB Baden-Württemberg | |
14.02.05 | GSK In-Line | Goldman Sachs | |
14.02.05 | GSK Halten | Helaba Trust | |
14.02.05 | GSK Outperformer | Sparkasse KölnBonn | |
11.02.05 | GSK Halten | Helaba Trust | |
11.02.05 | GSK Reduzieren | Independent Research | |
11.02.05 | GSK Outperform | Credit Suisse First Boston | |
10.02.05 | GSK Outperform | Credit Suisse First Boston | |
07.02.05 | GSK Outperform | Credit Suisse First Boston | |
03.02.05 | GSK Halten | Helaba Trust | |
19.01.05 | GSK Underweight | Morgan Stanley | |
18.01.05 | GSK Buy | Merrill Lynch | |
28.01.04 | GSK In-Line | Goldman Sachs |
Werbung
Werbung